title: 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications.
authors.affiliation: Seattle Children's Hospital, Seattle, Washington.
authors.forename: Sarah
authors.initials: S
authors.lastname: Ringold
authors.forename: Pamela F
authors.initials: PF
authors.lastname: Weiss
authors.forename: Timothy
authors.initials: T
authors.lastname: Beukelman
authors.forename: Esi Morgan
authors.initials: EM
authors.lastname: DeWitt
authors.forename: Norman T
authors.initials: NT
authors.lastname: Ilowite
authors.forename: Yukiko
authors.initials: Y
authors.lastname: Kimura
authors.forename: Ronald M
authors.initials: RM
authors.lastname: Laxer
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Lovell
authors.forename: Peter A
authors.initials: PA
authors.lastname: Nigrovic
authors.forename: Angela Byun
authors.initials: AB
authors.lastname: Robinson
authors.forename: Richard K
authors.initials: RK
authors.lastname: Vehe
mesh_terms: D000293:Adolescent; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001171:Arthritis, Juvenile / Q000188:drug therapy*; D001688:Biological Products / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D014376:Tuberculosis / Q000175:diagnosis* / Q000188:drug therapy
chemical_list: D018501:Antirheumatic Agents; D001688:Biological Products